...patite (HA) orbital implant was conceived by Arthu...rehensive review of the literature on orbital impl...ng back to 1885 (Mules 1885). This review, along w...e of contemporary implants, allowed Perry to ident...
...r Indirect Ophthalmo-Microscope) incorporates the ...ing microscope and enables a view of up to 130 deg... BIOM 3 the eye may be rotated freely so that the ...ery through small pupils is possible. The SDI ere...
...rt Home Defibrillatorthe latest in essential safet...eployed, Philips is the worldwide market leader in...orts, workplaces, communities, and homes. The Phil... only home defibrillator available without a presc...
Cadwell's custom bars have a large body for increased stability and solid, machined contacts (spaced 3 centimeters center-to-center) to resist the wear and tear of repeated cleaning. Polarity indicat
Medicine Products:(Date:10/13/2008)... New 1.5 million dollar NIH funding advance...arrest survival rates, MINNEAPOLIS, Oct. 13 /PRNe...tp://www.advancedcirculatory.com ) announced today...n funding from the National Institutes of,Health (...in combination on,those who experience cardiac arr...
(Date:10/13/2008)...evity,s Imperium(TM) Market Leading Content Rights... in Closing the Loop on Their Content Spend, WEST...LC announced,today that a leading global pharmaceu...ium technology to become the primary platform for ...racking and reporting,analytics for their new prod...
(Date:10/13/2008)...AN FRANCISCO, Oct. 13 /PRNewswire/ -- Michael Merz...er of Posit Science, has been elected,to the Insti...he Institute,today. Dr. Merzenich is one of 65 new...a highly selective process that recognizes,people ...nt of the medical,sciences, health care, and publi...
(Date:10/13/2008)...OMERSET, N.J., Oct. 13 /PRNewswire/ -- During the ... Center, primary care healthcare providers,took a ...healthcare IT,company based in Somerset, NJ. The q...ims submission, reimbursement, EMR software, and h...handful scored less than 50%. The average number,o...
Breaking Medicine News(10 mins):Health News:3 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:Merzenich Elected to Institute of Medicine 2Health News:Merzenich Elected to Institute of Medicine 3Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2(Date:10/10/2008)...nd MENLO PARK, Calif., Oct. 10 /PRNewswire-FirstCa...d that it plans to present,long-term follow-up dat...xt,week at the Cardiovascular Research Foundation,...lar Therapeutics (TCT) meeting in Washington, DC.,... designed to investigate,the safety and efficacy o...
(Date:10/10/2008)... Show Prophylaxis Treatment with Kogenate FS Reduc... Children with No Pre-Existing,Joint Damage, BERK...Care LLC,announced today that the U.S. Food and Dr...ylaxis with Kogenate(R) FS Antihemophilic Factor,(...pisodes and the risk of,joint damage in patients a...
(Date:10/10/2008)...., Oct. 10 /- Boston Scient... schedule of the Company,s major,events and press ...ation,s,(CRF) twentieth annual Transcatheter Cardi... which runs from October 12 to 17 in Washington, D...range of safety and,efficacy data on its TAXUS(R) ...
(Date:10/9/2008)...an Campaign to Spread Awareness and Bring Hope to .../PRNewswire-USNewswire/ -- 133 million children,ac...uses such as natural,disaster, civil war, and dise...rving World Orphan Week by calling attention to th...edia News Release, go to:, http://www.prnewswire...
Breaking Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Consistency Flexibility Key in Improving Rewards 26 Recognition Programs 7079 1Consistency Flexibility Key in Improving Rewards 26 Recognition Programs 7079 2Telik Announces Financial Results For 2008 Second Quarter 7076 1Telik Announces Financial Results For 2008 Second Quarter 7076 2Telik Announces Financial Results For 2008 Second Quarter 7076 3Telik Announces Financial Results For 2008 Second Quarter 7076 4Researchers Hunt Normal Cells That Give Rise to Cancer 25275 1Researchers Hunt Normal Cells That Give Rise to Cancer 25275 2Lack of Vitamin D Boosts Death Risk 25272 1Lack of Vitamin D Boosts Death Risk 25272 2Lack of Vitamin D Boosts Death Risk 25272 3...Apr 23, 2007 - CytRx Corporation,(NASDAQ:CYTR) tod...very technology exclusively licensed to its majori...on (RXi), has been,published in the April 2007 iss...l Biology. The technology was developed by RXi,Co-...ersity of,Massachusetts Medical School (UMMS) Prof...
...PRNewswire/ -- Sirion Therapeutics,announced today...nds, ST-601 (difluprednate) and ST-602 (fenretinid...f The Association for,Research in Vision and Ophth... to these presentations, the company will be hosti...prednate) is currently being evaluated in two phas...
Other Medicine Technology:CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 2CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 4Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 2Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 3Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 4